Blood · 2014
Phosphoinositide 3-kinase β mediates microvascular endothelial repair of thrombotic microangiopathy.
СтатьяПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Haddad George, Zhabyeyev Pavel, Farhan Maikel, Zhu Lin Fu, Kassiri Zamaneh, Rayner David C, Vanhaesebroeck Bart, Oudit Gavin Y, Murray Allan G
Аннотация
Thrombotic microangiopathy (TMA) commonly involves injury of kidney glomerular endothelial cells (ECs) and fibrin occlusion of the capillaries. The mechanisms underlying repair of the microvasculature and recovery of kidney function are poorly defined. In the developing vasculature, the phosphoinositide 3-kinase (PI3K) α isoform integrates many growth factor cues. However, the role of individual isoforms in repair of the established vasculature is unclear. We found that postnatal endothelial deletion of PI3Kβ sensitizes mice to lethal acute kidney failure after TMA injury. In vitro, PI3Kβ-deficient ECs show reduced angiogenic invasion of fibrin matrix with unaltered sensitivity to proapoptotic stress compared with wild-type ECs. This correlates with decreased expression of the EC tip cell markers apelin and Dll4 and is associated with a reduction in migration and proliferation. In vivo, PI3Kβ-knockdown ECs are deficient in assembly of microvessel-like structures. These data identify a critical role for endothelial PI3Kβ in microvascular repair following injury.
Предметные рубрики MeSH
AnimalsApoptosisBiomarkersClass II Phosphatidylinositol 3-KinasesDisease Models, AnimalEndothelial CellsEndothelium, VascularEnzyme ActivationHumansKidney GlomerulusMiceMice, KnockoutMicrovesselsPTEN PhosphohydrolasePhosphorylationProto-Oncogene Proteins c-aktThrombotic MicroangiopathiesVascular Endothelial Growth Factor A